<DOC>
	<DOCNO>NCT01063036</DOCNO>
	<brief_summary>The purpose study show combination entecavir tenofovir , effective well tolerate chronic hepatitis B patient fail previous treatment .</brief_summary>
	<brief_title>Efficacy Safety Study Entecavir Plus Tenofovir Patients With Chronic Hepatitis B Who Failed Previous Treatment</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Subjects chronic hepatitis B virus ( HBV ) infection ; either hepatitis Be antigen ( HBeAg ) negative HBeAgpositive Subjects must treatment failure current nucleoside/ nucleotide treatment regimen Prior entecavir and/or tenofovir monotherapy allow Subjects must compensate liver function Women pregnant breastfeed Evidence decompensated cirrhosis Coinfection HIV , hepatitis C virus ( HCV ) , hepatitis D virus ( HDV ) Moderate severe renal impairment Recent history pancreatitis Therapy interferon , thymosin alpha immunostimulators within 24 week assign study drug study Prior entecavir/tenofovir combination therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>